KTTA · Categories · Form 4

KTTA - SEC Form 4 insider transactions

Pasithea Therapeutics Corp. (KTTA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for KTTA

• 146d
  Chief Financial Officer Schneiderman Daniel H was granted 26,667 shares (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 146d
  Director Leahy Emer was granted 33,333 shares (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 181d
  SEC Form 4 filed by Director Steinman Lawrence

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 181d
  SEC Form 4 filed by Chief Financial Officer Schneiderman Daniel H

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 181d
  SEC Form 4 filed by Chief Executive Officer Marques Tiago

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 181d
  SEC Form 4 filed by Director Leahy Emer

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 181d
  SEC Form 4 filed by Director Dumesnil Simon

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 181d
  SEC Form 4 filed by Director Novak Alfred J

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 347d
  Chief Executive Officer Marques Tiago sold $792 worth of shares (960 units at $0.82), decreasing direct ownership by 2% to 40,001 units (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 681d
  Director Novak Alfred J was granted 3,500 shares (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 751d
  SEC Form 4 filed by Marques Tiago (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 751d
  SEC Form 4 filed by Schneiderman Daniel H (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 751d
  SEC Form 4 filed by Dumesnil Simon (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 751d
  SEC Form 4 filed by Leahy Emer (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 751d
  SEC Form 4 filed by Novak Alfred J (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 751d
  SEC Form 4 filed by Steinman Lawrence (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 751d
  SEC Form 4 filed by Currie Graeme Martin (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 786d
  SEC Form 4 filed by Steinman Lawrence

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 786d
  SEC Form 4 filed by Schneiderman Daniel H

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 786d
  SEC Form 4 filed by Novak Alfred J

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 786d
  SEC Form 4 filed by Marques Tiago

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 786d
  SEC Form 4 filed by Leahy Emer

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 786d
  SEC Form 4 filed by Dumesnil Simon

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 786d
  SEC Form 4 filed by Currie Graeme Martin

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1055d
  SEC Form 4 filed by Steinman Lawrence (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1055d
  SEC Form 4 filed by Steinman Lawrence

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1245d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.39% to 1,287,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1245d
  SEC Form 4: Marques Tiago was granted 9,206 shares, increasing direct ownership by 1% to 819,206 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1251d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.39% to 1,282,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1256d
  SEC Form 4: Dumesnil Simon was granted 50,000 shares

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1278d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.39% to 1,277,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1280d
  SEC Form 4 filed by Novak Alfred J

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1283d
  SEC Form 4: Marques Tiago was granted 5,000 shares, increasing direct ownership by 0.62% to 810,000 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1285d
  SEC Form 4: Delaney David bought $1,110 worth of shares (1,000 units at $1.11)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1287d
  SEC Form 4: Steinman Lawrence was granted 10,000 shares, increasing direct ownership by 0.79% to 1,272,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1292d
  SEC Form 4 filed by Schneiderman Daniel H

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1304d
  SEC Form 4: Shahinian Eric bought $76,299 worth of shares (64,357 units at $1.19)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1328d
  SEC Form 4: Shahinian Eric bought $100,367 worth of shares (88,901 units at $1.13)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1334d
  SEC Form 4: Shahinian Eric bought $26,293 worth of shares (22,828 units at $1.15)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1339d
  SEC Form 4: Geller Avi bought $70,939 worth of shares (54,644 units at $1.30)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1347d
  SEC Form 4: Shahinian Eric bought $188,283 worth of shares (155,773 units at $1.21)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1396d
  SEC Form 4: Steinman Lawrence was granted 10,000 shares, increasing direct ownership by 0.79% to 1,272,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1399d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.40% to 1,262,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1403d
  SEC Form 4: Marques Tiago was granted 5,000 shares, increasing direct ownership by 0.62% to 805,000 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1403d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.40% to 1,257,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1404d
  SEC Form 4: Steinman Lawrence was granted 652,174 shares, increasing direct ownership by 109% to 1,252,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1586d
  SEC Form 4: Marques Tiago was granted 200,000 shares, increasing direct ownership by 33% to 800,000 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)

Other KTTA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends